Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
Journal of Virology · 2024
DOI: 10.1128/jvi.01386-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Yoshihiro Izumiya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Immediate-Early Proteins, Sarcoma, Kaposi. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | NIH | National Cancer Institute.
Abstract (Originalsprache)
Enhancers are a crucial regulator of differential gene expression programs. Enhancers are the cis-regulatory sequences determining target genes’ spatiotemporal and quantitative expression. Here, we show that Kaposi’s sarcoma-associated herpesvirus (KSHV) terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters. The KSHV enhancer is occupied by latency-associated nuclear antigen (LANA) and its interacting proteins, such as CHD4. Neighboring terminal repeat (TR) fragments to lytic gene promoters drastically enhanced KSHV replication and transcription activator and LANA transcription regulatory functions. This study, thus, proposes a new latency–lytic switch model in which TR accessibility to the KSHV gene promoters regulates viral inducible gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, University of California Davis, Sacramento, California, USA.
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, California, USA.
- Midwestern University College of Dental Medicine, Glendale, Arizona, USA.
ORCID-Profile: Yoshihiro Izumiya
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- HHS | NIH | National Cancer Institute
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Izumiya, Y., Algalil, A., Espera, J. M., Miura, H., Izumiya, C., Inagaki, T., & Kumar, A. (2024). Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters. Journal of Virology. https://doi.org/10.1128/jvi.01386-23
Vancouver
Izumiya Y, Algalil A, Espera JM, Miura H, Izumiya C, Inagaki T, et al. Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters. Journal of Virology. 2024. doi:10.1128/jvi.01386-23
BibTeX
@article{Izumiya2024,
author = {Izumiya, Yoshihiro and Algalil, Adhraa and Espera, Jonna M and Miura, Hiroki and Izumiya, Chie and Inagaki, Tomoki and Kumar, Ashish},
title = {Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01386-23}
}
EUVIMED